Centessa Pharmaceuticals (CNTA) Insider Trading & Ownership $14.34 +0.60 (+4.33%) As of 07/3/2025 02:56 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Centessa Pharmaceuticals (NASDAQ:CNTA) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage7.09%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$5.87MNumber OfInsiders Selling(Last 12 Months)7Amount OfInsider Selling(Last 12 Months)$17.75M Get CNTA Insider Trade Alerts Want to know when executives and insiders are buying or selling Centessa Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address CNTA Insider Buying and Selling by Quarter Centessa Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails6/25/2025Gregory M WeinhoffInsiderSell10,000$13.86$138,600.00 6/24/2025Iqbal J HussainGeneral CounselSell12,000$14.02$168,240.00 6/24/2025Mario Alberto AccardiInsiderSell15,000$14.00$210,000.00 6/20/2025Saurabh SahaCEOSell55,000$12.63$694,650.00 5/27/2025Gregory M WeinhoffInsiderSell10,000$12.82$128,200.00 5/20/2025Saurabh SahaCEOSell55,000$12.71$699,050.00 5/16/2025Arjun GoyalDirectorBuy417,646$12.73$5,316,633.58 5/15/2025Arjun GoyalDirectorBuy44,939$12.24$550,053.36 5/1/2025Iqbal J HussainGeneral CounselSell311$14.00$4,354.00 4/28/2025Iqbal J HussainGeneral CounselSell2,080$14.01$29,140.80 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 4/25/2025Gregory M WeinhoffInsiderSell11,742$13.61$159,808.62 4/25/2025Iqbal J HussainGeneral CounselSell3,609$14.00$50,526.00 4/21/2025Saurabh SahaCEOSell14,656$12.29$180,122.24 3/25/2025Gregory M WeinhoffInsiderSell10,000$16.34$163,400.00 3/20/2025Saurabh SahaCEOSell55,000$16.69$917,950.00 3/17/2025David M ChaoInsiderSell7,000$17.17$120,190.00 3/17/2025Iqbal J HussainGeneral CounselSell6,000$16.45$98,700.00 2/20/2025Saurabh SahaCEOSell55,000$15.93$876,150.00 2/18/2025Iqbal J HussainGeneral CounselSell6,000$16.18$97,080.00 2/10/2025Karen M AndersonInsiderSell429$18.99$8,146.71 2/7/2025Karen M AndersonInsiderSell30,526$19.03$580,909.78 2/3/2025Karen M AndersonInsiderSell6,471$16.86$109,101.06 2/3/2025Tia L BushCTOSell11,000$16.86$185,460.00 1/27/2025Gregory M WeinhoffInsiderSell11,742$16.47$193,390.74 1/21/2025Saurabh SahaCEOSell55,000$15.77$867,350.00 1/15/2025Iqbal J HussainGeneral CounselSell6,000$15.29$91,740.00 12/26/2024Gregory M WeinhoffInsiderSell10,000$17.04$170,400.00 12/20/2024Saurabh SahaCEOSell55,000$17.44$959,200.00 12/17/2024Karen M AndersonInsiderSell10,624$17.32$184,007.68 12/17/2024Tia L BushCTOSell17,813$18.00$320,634.00 12/16/2024Iqbal J HussainGeneral CounselSell77,705$16.39$1,273,584.95 12/13/2024Karen M AndersonInsiderSell5,876$17.01$99,950.76 12/6/2024Saurabh SahaCEOSell87,496$18.46$1,615,176.16 11/25/2024Gregory M WeinhoffInsiderSell10,000$17.66$176,600.00 11/25/2024Saurabh SahaCEOSell299$18.23$5,450.77 11/22/2024Saurabh SahaCEOSell1,671$18.24$30,479.04 11/20/2024Saurabh SahaCEOSell55,000$16.89$928,950.00 10/25/2024Gregory M WeinhoffInsiderSell11,742$15.38$180,591.96 10/23/2024Saurabh SahaCEOSell2,592$15.32$39,709.44 10/21/2024Saurabh SahaCEOSell22,205$15.80$350,839.00 Why Is President Trump Fast-Tracking These Companies? (Ad)Forget about AI… There's a hot new trend on Wall Street… and it's all thanks to President Trump. His administration has begun to fast-track the operations of a handful of companies… Accelerating their potential profits. That's why legendary investor Louis Navellier is now recommending these three stocks that are being fast-tracked.Click here to see the details on what the Financial Times called...9/25/2024Gregory M WeinhoffInsiderSell16,619$15.69$260,752.11 9/20/2024Saurabh SahaCEOSell55,000$16.53$909,150.00 9/10/2024Saurabh SahaCEOSell175,000$16.52$2,891,000.00 9/9/2024Gregory M WeinhoffInsiderSell25,000$15.00$375,000.00 8/22/2024Gregory M WeinhoffInsiderSell12,198$12.17$148,449.66 8/22/2024Saurabh SahaCEOSell506$12.23$6,188.38 8/20/2024Saurabh SahaCEOSell4,169$12.32$51,362.08 (Data available from 1/1/2013 forward) CNTA Insider Trading Activity - Frequently Asked Questions Who is on Centessa Pharmaceuticals' Insider Roster? The list of insiders at Centessa Pharmaceuticals includes Antoine Yver, Arjun Goyal, David M Chao, Gregory M Weinhoff, Harris Rotman, Iqbal J Hussain, Karen M Anderson, Mario Alberto Accardi, Saurabh Saha, Thomas Templeman, and Tia L Bush. Learn more on insiders at CNTA. What percentage of Centessa Pharmaceuticals stock is owned by insiders? 7.09% of Centessa Pharmaceuticals stock is owned by insiders. Learn more on CNTA's insider holdings. Which Centessa Pharmaceuticals insiders have been buying company stock? The following insider purchased CNTA shares in the last 24 months: Arjun Goyal ($5,866,686.94). How much insider buying is happening at Centessa Pharmaceuticals? Insiders have purchased a total of 462,585 CNTA shares in the last 24 months for a total of $5,866,686.94 bought. Which Centessa Pharmaceuticals insiders have been selling company stock? The following insiders have sold CNTA shares in the last 24 months: David M Chao ($120,190.00), Gregory M Weinhoff ($2,095,193.09), Harris Rotman ($270,337.06), Iqbal J Hussain ($1,813,365.75), Karen M Anderson ($1,589,896.79), Mario Alberto Accardi ($210,000.00), Saurabh Saha ($12,022,777.11), and Tia L Bush ($506,094.00). How much insider selling is happening at Centessa Pharmaceuticals? Insiders have sold a total of 1,198,992 Centessa Pharmaceuticals shares in the last 24 months for a total of $18,627,853.80 sold. More Insider Trading Tools from MarketBeat Related Companies Grifols Insider Transactions TG Therapeutics Insider Transactions Lantheus Insider Transactions Nuvalent Insider Transactions Axsome Therapeutics Insider Transactions Akero Therapeutics Insider Transactions Vaxcyte Insider Transactions ADMA Biologics Insider Transactions PTC Therapeutics Insider Transactions Rhythm Pharmaceuticals Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insider Selling at NVIDIA Could Turn Into an Opportunity The Top Insider Sells From Q2: Buy, Sell, or Hold?3 Hot Trades for Insiders, But Are They Good Buys for Investors?Insiders Chase Income and Stability in American Tower—Here’s Why3 Tech Stocks With High and Rising Institutional Interest This page (NASDAQ:CNTA) was last updated on 7/4/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredWhy Is President Trump Fast-Tracking These Companies?Forget about AI… There's a hot new trend on Wall Street… and it's all thanks to President Trump. His administr...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Centessa Pharmaceuticals PLC Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Centessa Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CNTA Stock Alerts